Skip to content
Search
Can smaller be stronger?

US Smaller Companies Equity

The US small and mid-cap universe represents a diverse mix of businesses – from established industry leaders to new and innovative “micro-caps” – whose strengths often remain underappreciated, or even unknown, by the broader investment community.

Three reasons to consider this strategy

Opportunity:

We look for underfollowed companies possessing attractive fundamentals where identification of a “value creation” catalyst is key.

Flexibility: 

We seek to invest in the most attractive opportunities across the small-/mid-cap universe from deep value to aggressive growth companies.

Diversification:

The portfolio maintains a blend of value and growth stocks, broadly diversified among sectors and industries seeking to limit volatility.

US Smaller Companies Equity

An actively managed, widely diversified portfolio of around 150 to 200 smaller cap companies in the US, with a core style orientation that maintains broad exposure to both growth and value stocks.

Find out more

Download our fund materials

SICAV Product Story US Equities matrix (SICAV) US Equities brochure

General Portfolio Risks. Capital risk – the value of your investment will vary and is not guaranteed. It will be affected by changes in the exchange rate between the base currency of the portfolio and the currency in which you subscribed, if different. Equity risk – in general, equities involve higher risks than bonds or money market instruments. Geographic concentration risk – to the extent that a portfolio invests a large portion of its assets in a particular geographic area, its performance will be more strongly affected by events within that area. Hedging risk – a portfolio's attempts to reduce or eliminate certain risks through hedging may not work as intended. Investment portfolio risk – investing in portfolios involves certain risks an investor would not face if investing in markets directly. Management risk – the investment manager or its designees may at times find their obligations to a portfolio to be in conflict with their obligations to other investment portfolios they manage (although in such cases, all portfolios will be dealt with equitably). Operational risk – operational failures could lead to disruptions of portfolio operations or financial losses.

Sign up for further US Equities insights including:

  • What investors can learn from past election cycles
  • What the future holds for US equity investors
  • Could 2024 prove to be a turning point for US small caps?

By providing your contact information and ticking the box below, you agree to subscribe to receive information from T. Rowe Price about its products and strategies as listed above by email or post. For information about how T. Rowe Price processes your personal data, please see the T. Rowe Price privacy notice.

We utilise the full opportunity set, from out-of-favour smaller companies with strong potential for improvement, to companies that may appear fully valued but whose long term growth potential is underappreciated.
Matt Mahon Co-Portfolio Manager
View Transcript

Smaller-cap valuations have been relatively attractive versus their large cap peers for some time now. But valuation alone is not a catalyst for outperformance. You need valuation, but you also need fundamentals. Over the coming years, we’ve seen an inflection in small-cap fundamentals as industries like industrials and the energy complex improve relative to the past. Those inflecting fundamentals support many of the smaller companies and in aggregate will help small-cap earnings on a relative basis versus their large-cap peers, providing a tailwind to the fundamentals for these businesses. Today, we're finding attractive opportunities in the energy complex as falling energy productivity, the unwinding of the shale revolution, is creating the need for greater investment in the energy industry, and in suppliers that help combat falling productivity. As well, we're finding attractive areas of opportunity in health care, as the next generation of medicine takes hold in some of the most innovative companies that are driving that change. We're seeing an extreme bifurcation where parts of a given industry are performing very well, as in the AI companies within the semiconductor universe. But within semiconductors, there's also parts that are experiencing deeply recessionary volumes, like analog and microcontrollers and diodes.

Two questions on US equities with…Matt Mahon

Portfolio Manager Matt Mahon discusses his outlook and expectations for US smaller companies

You might be interested in

US Large Cap Growth Equity

“Shoot-the-lights-out” stocks with explosive earnings growth rates may capture the markets’ attention, but they are rarely long term winners. Identifying companies that have the potential for durable high growth demands research that goes beyond the day-to-day headlines.

Read more
US All Cap Opportunities Equity

Maximising your opportunity set across styles and market caps is one thing. Being able to evaluate and form a view on a much broader universe is another. It requires an incredible depth of talent, experience, knowledge and insight to fully exploit the flexibility that an all-cap approach can offer. 

Read more
US Structured Research Equity

US equities continue to dominate global stock markets, providing access to many of the world’s leading companies. But investors worried about relying on the market’s continued strength may want to consider a strategy that aims to blend the best of active and passive investing.

Read more
US Equities

US Equities: Expert analysis. Better decisions. 

Our success in US Equities is driven by 87 years of expert analysis. We’re constantly asking the right questions to the right people, to make better investment decisions. 

Explore Further
US Election

US Election 2024

Our team of experts assess the key policies and the potential impacts on the economy, financial markets and investment portfolios.

Explore Further

202409-3833299 

Important Information

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. 

It is not intended for distribution to retail investors in any jurisdiction.

© 2024 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/ or apart, trademarks of T. Rowe Price Group, Inc.